Literature DB >> 3218910

The prevalence of insomnia: the importance of operationally defined criteria.

B Liljenberg1, M Almqvist, J Hetta, B E Roos, H Agren.   

Abstract

Previous studies on the prevalence of sleep disturbances have shown that insomnia occurs in 3.2-42% of different populations. The wide reported variation in prevalence prompted a rigorous definition of insomnia to be introduced in this study. Randomly selected members of the population aged 30 to 65 years from two geographically different rural parts of central Sweden answered a sleep questionnaire. The response rates were 69.2% and 70.2%, respectively. Females significantly more often reported difficulty in falling asleep (7.1% of the women and 5.1% of the men). Among women 8.9 and among men 7.7% of individuals reported trouble with nocturnal awakenings. Using a stringently defined concept of insomnia as a disorder of initiating sleep (DIS), the prevalence rate of insomnia among women was 1.1% and among men 0.5%. Defining insomnia as a disorder of maintaining sleep (DMS), the prevalence among both women and men was 1.1%. Defining insomnia as a disorder of initiating and maintaining sleep (DIMS), the prevalence rate was 1.7% among women and 1.4% among men. This prevalence, which is lower than previously reported, demonstrate the importance of an operational definition of insomnia.

Entities:  

Mesh:

Year:  1988        PMID: 3218910

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  15 in total

1.  Job stress and poor sleep quality: data from an American sample of full-time workers.

Authors:  Hannah K Knudsen; Lori J Ducharme; Paul M Roman
Journal:  Soc Sci Med       Date:  2007-03-23       Impact factor: 4.634

2.  Psychosocial work stressors for insomnia: a prospective study on 50-60-year-old adults in the working population.

Authors:  Markus Jansson-Fröjmark; Daniel Lundqvist; Nina Lundqvist; Steven J Linton
Journal:  Int J Behav Med       Date:  2007

3.  Sleep disordered breathing, hypoxia and inflammation: associations with sickness behaviour in community dwelling elderly with and without cardiovascular disease.

Authors:  Peter Johansson; Erland Svensson; Urban Alehagen; Ulf Dahlström; Tiny Jaarsma; Anders Broström
Journal:  Sleep Breath       Date:  2014-05-25       Impact factor: 2.816

4.  Is there a bidirectional link between insomnia and burnout? A prospective study in the Swedish workforce.

Authors:  Markus Jansson-Fröjmark; Karin Lindblom
Journal:  Int J Behav Med       Date:  2010-12

5.  Prevalence of insomnia and its relationship to the health habits or status of women living along a city road part 1. epidemiologie study.

Authors:  T Kawada; K Yasuo; S Yosiaki; S Suzuki
Journal:  Environ Health Prev Med       Date:  1997-01       Impact factor: 3.674

6.  Prevalence and treatment of insomnia in general practice. A longitudinal study.

Authors:  F Hohagen; K Rink; C Käppler; E Schramm; D Riemann; S Weyerer; M Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 7.  From wakefulness to excessive sleepiness: what we know and still need to know.

Authors:  Maurice Moyses Ohayon
Journal:  Sleep Med Rev       Date:  2008-04       Impact factor: 11.609

8.  Sleep habits, insomnia, and daytime sleepiness in a large and healthy community-based sample of New Zealanders.

Authors:  Bradley R Wilsmore; Ronald R Grunstein; Marlene Fransen; Mark Woodward; Robyn Norton; Shanthi Ameratunga
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

9.  The course of insomnia over one year: a longitudinal study in the general population in Sweden.

Authors:  Markus Jansson-Fröjmark; Steven J Linton
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

10.  Health predicting factors in a general population over an eight-year period in subjects with and without chronic musculoskeletal pain.

Authors:  Susann Arvidsson; Barbro Arvidsson; Bengt Fridlund; Stefan Bergman
Journal:  Health Qual Life Outcomes       Date:  2008-11-11       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.